Substance use disorders in schizophrenia--clinical implications of comorbidity
- PMID: 19325163
- PMCID: PMC2669586
- DOI: 10.1093/schbul/sbp016
Substance use disorders in schizophrenia--clinical implications of comorbidity
Abstract
Nearly half of the people suffering from schizophrenia also present with a lifetime history of substance use disorders (SUD), a rate that is much higher than the one seen among unaffected individuals. This phenomenon suggests that the factors influencing SUD risk in schizophrenia may be more numerous and/or complex than those modulating SUD risk in the general population. It is critically important to address this comorbidity because SUD in schizophrenic patients is associated with poorer clinical outcomes and contributes significantly to their morbidity and mortality.
References
-
- Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511–2518. - PubMed
-
- Swofford CD, Scheller-Gilkey G, Miller AH, Woolwine B, Mance R. Double jeopardy: schizophrenia and substance use. Am J Drug Alcohol Abuse. 2000;26:343–353. - PubMed
-
- de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76:135–157. - PubMed
-
- Dervaux A, Laqueille X. Smoking and schizophrenia: epidemiological and clinical features. Encephale. 2008;34:299–305. - PubMed
-
- Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003;326:223–230. - PubMed
